Skip to main navigation Skip to search Skip to main content

Dacomitinib-induced purpuric drug eruptions associated with IQGAP1 upregulation in a patient with lung adenocarcinoma

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)795-797
Number of pages3
JournalJDDG - Journal of the German Society of Dermatology
Volume21
Issue number7
DOIs
Publication statusPublished - Jul 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Humans
  • Adenocarcinoma of Lung
  • Drug Eruptions/diagnosis
  • Lung Neoplasms/drug therapy
  • Mutation
  • Protein Kinase Inhibitors
  • Up-Regulation

Cite this